Central serous chorioretinopathy in uveitis patients after corticosteroid therapy: a report of 6 cases
Purpose. To report central serous chorioretinopathy (CSCR) in uveitis patients.Material and methods. A retrospective chart review of uveitis patients seen in a time frame of 20 years at the Centre for Ophthalmic Specialised Care, Lausanne, Switzerland. The ophthalmic and systemic features are presen...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Real Time Ltd
2021-09-01
|
| Series: | Российский офтальмологический журнал |
| Subjects: | |
| Online Access: | https://roj.igb.ru/jour/article/view/720 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849395994615087104 |
|---|---|
| author | N. A. Skvortsova I. Papasavvas C. P. Herbort Jr |
| author_facet | N. A. Skvortsova I. Papasavvas C. P. Herbort Jr |
| author_sort | N. A. Skvortsova |
| collection | DOAJ |
| description | Purpose. To report central serous chorioretinopathy (CSCR) in uveitis patients.Material and methods. A retrospective chart review of uveitis patients seen in a time frame of 20 years at the Centre for Ophthalmic Specialised Care, Lausanne, Switzerland. The ophthalmic and systemic features are presented.Results. Out of 1793 uveitis patients followed at the Centre for Ophthalmic Specialised Care, 6 patients (0.3%) developed CSСR following corticosteroid therapy due to uveitis. The mean age of patients was 40 ± 13.4 years, disease incidence was not associated with gender. In all 6 patients’ clinical disease was unilateral but subclinical signs were present in all fellow eyes. The mean duration of corticosteroid therapy before CSCR had occurred was 4.95 ± 4.0 months. The mean best-corrected visual acuity at the moment of CSCR was 0.6 ± 0.26 and 0.8 ± 0.17 after discontinuation of corticosteroids. Neurosensory retinal detachment and pigment epithelium detachment were observed in 3 eyes, respectively. During fluorescein angiography (FA), focal dye leakage and areas of alteration of RPE were observed in 6 out of 10 eyes. Diffuse hyperfluorescence of choroidal vessels observed by ICGA was detected in all eyes.Conclusion. Central serous chorioretinopathy should be suspected when functional and morphological deterioration occurs in uveitis patients receiving corticosteroid therapy with no signs of inflammation reactivation. This complication is extremely rare but serious condition which needs a prompt tapering and discontinuing of corticosteroids. |
| format | Article |
| id | doaj-art-42d424523e5f46b99aac466e5e428d89 |
| institution | Kabale University |
| issn | 2072-0076 2587-5760 |
| language | Russian |
| publishDate | 2021-09-01 |
| publisher | Real Time Ltd |
| record_format | Article |
| series | Российский офтальмологический журнал |
| spelling | doaj-art-42d424523e5f46b99aac466e5e428d892025-08-20T03:39:28ZrusReal Time LtdРоссийский офтальмологический журнал2072-00762587-57602021-09-01143657210.21516/2072-0076-2021-14-3-65-72375Central serous chorioretinopathy in uveitis patients after corticosteroid therapy: a report of 6 casesN. A. Skvortsova0I. Papasavvas1C. P. Herbort Jr2Posterior Eye Segment Diagnostics and Surgery Center; Inflammatory and Retinal Eye Diseases, Centre for Ophthalmic Specialised careInflammatory and Retinal Eye Diseases, Centre for Ophthalmic Specialised careInflammatory and Retinal Eye Diseases, Centre for Ophthalmic Specialised carePurpose. To report central serous chorioretinopathy (CSCR) in uveitis patients.Material and methods. A retrospective chart review of uveitis patients seen in a time frame of 20 years at the Centre for Ophthalmic Specialised Care, Lausanne, Switzerland. The ophthalmic and systemic features are presented.Results. Out of 1793 uveitis patients followed at the Centre for Ophthalmic Specialised Care, 6 patients (0.3%) developed CSСR following corticosteroid therapy due to uveitis. The mean age of patients was 40 ± 13.4 years, disease incidence was not associated with gender. In all 6 patients’ clinical disease was unilateral but subclinical signs were present in all fellow eyes. The mean duration of corticosteroid therapy before CSCR had occurred was 4.95 ± 4.0 months. The mean best-corrected visual acuity at the moment of CSCR was 0.6 ± 0.26 and 0.8 ± 0.17 after discontinuation of corticosteroids. Neurosensory retinal detachment and pigment epithelium detachment were observed in 3 eyes, respectively. During fluorescein angiography (FA), focal dye leakage and areas of alteration of RPE were observed in 6 out of 10 eyes. Diffuse hyperfluorescence of choroidal vessels observed by ICGA was detected in all eyes.Conclusion. Central serous chorioretinopathy should be suspected when functional and morphological deterioration occurs in uveitis patients receiving corticosteroid therapy with no signs of inflammation reactivation. This complication is extremely rare but serious condition which needs a prompt tapering and discontinuing of corticosteroids.https://roj.igb.ru/jour/article/view/720uveitistreatmentcentral serous chorioretinopathycorticosteroids |
| spellingShingle | N. A. Skvortsova I. Papasavvas C. P. Herbort Jr Central serous chorioretinopathy in uveitis patients after corticosteroid therapy: a report of 6 cases Российский офтальмологический журнал uveitis treatment central serous chorioretinopathy corticosteroids |
| title | Central serous chorioretinopathy in uveitis patients after corticosteroid therapy: a report of 6 cases |
| title_full | Central serous chorioretinopathy in uveitis patients after corticosteroid therapy: a report of 6 cases |
| title_fullStr | Central serous chorioretinopathy in uveitis patients after corticosteroid therapy: a report of 6 cases |
| title_full_unstemmed | Central serous chorioretinopathy in uveitis patients after corticosteroid therapy: a report of 6 cases |
| title_short | Central serous chorioretinopathy in uveitis patients after corticosteroid therapy: a report of 6 cases |
| title_sort | central serous chorioretinopathy in uveitis patients after corticosteroid therapy a report of 6 cases |
| topic | uveitis treatment central serous chorioretinopathy corticosteroids |
| url | https://roj.igb.ru/jour/article/view/720 |
| work_keys_str_mv | AT naskvortsova centralserouschorioretinopathyinuveitispatientsaftercorticosteroidtherapyareportof6cases AT ipapasavvas centralserouschorioretinopathyinuveitispatientsaftercorticosteroidtherapyareportof6cases AT cpherbortjr centralserouschorioretinopathyinuveitispatientsaftercorticosteroidtherapyareportof6cases |